NIH-funded research NIH-funded research

How blood vessel and immune cell metabolism shapes artery disease

Official title: Insights into the molecular mechanisms regulating vascular and immune metabolism in vascular diseases

Funded at Yale University · NIH-11245748 · Data updated 2026-11-12

This project looks at how changes in energy use inside artery-lining cells, artery muscle cells, and immune cells affect people with atherosclerosis.

More Vascular Diseases research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJanuary 15, 2021
Project endDecember 31, 2027
Funding year2026
Award (this year)$929,229
NIH project number5R35HL155988-06
Project IDNIH-11245748 on NIH RePORTER

Who could benefit from this research

Could help

Adults with atherosclerotic cardiovascular disease, such as coronary artery disease or carotid plaque, who can provide blood or tissue samples during clinical visits or procedures would be the most relevant participants.

Less likely to help

People without atherosclerosis or those with unrelated health problems are unlikely to see direct benefits from this laboratory-focused research.

What this research studies

Researchers will examine the cells that line blood vessels (endothelial cells), the muscle cells in vessel walls (smooth muscle cells), and immune cells that collect in arterial plaques. They will focus on how shifts in cell metabolism and small regulatory RNAs called microRNAs change cell behavior and plaque stability, using lab-grown cells, animal models, and human tissue or blood samples. The team will test whether these metabolic pathways make plaques more likely to grow or rupture. The goal is to identify metabolic switches that could become targets for new treatments or diagnostics.

Why it matters

Potential benefit: If successful, this work could point to new ways to stabilize plaques and reduce heart attacks and strokes.

How similar studies have gone: Prior laboratory studies have shown that microRNAs and cellular metabolism affect vascular cells, but turning those findings into tested treatments for patients remains an early and active area of research.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Suarez, Yajaira — Yale University
  • Study coordinator: Suarez, Yajaira

Related research

Other NIH-funded projects on the same topics.

  • Topical HIF-1 inhibitors to treat retinal and choroidal vascular diseases

    A Johns Hopkins team is testing eye drops that block HIF-1 to help people with retinal and choroidal blood vessel problems respond better to treatment.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11418368

  • A portable photoacoustic device to help diagnose vascular diseases

    A small, battery-powered imaging tool uses light and sound to help detect blood vessel problems at the point of care without harming patients.

    NIH research Pennsylvania State University, the · University Park, United States · NIH-11393173

  • Mitochondrial function and retinal blood vessel disease

    This grant explores how tiny power plants inside cells (mitochondria) influence the growth of retinal blood vessels in conditions like age-related macular degeneration and diabetic eye disease, with the goal of finding new paths to protect vision.

    NIH research University of Virginia · Charlottesville, United States · NIH-11384336

  • Handheld light-and-sound scanner for blood vessel problems

    A portable device that uses safe light-plus-ultrasound imaging to find and monitor blood vessel problems for people with conditions like diabetes or peripheral artery disease.

    NIH research Pennsylvania State University, the · University Park, United States · NIH-11182724

  • How mitochondria affect retinal blood vessel health

    This project looks at whether problems in mitochondria change how blood vessels grow in the retina, which matters to people with conditions like diabetic retinopathy or other retinal blood-vessel diseases.

    NIH research Yale University · New Haven, United States · NIH-11143745

  • Eye drops that block HIF-1 for wet macular degeneration and choroidal neovascularization

    Trying an eye drop that blocks HIF‑1 to reduce abnormal blood vessel growth in people with wet age-related macular degeneration.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11118836

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.